Adipotide vs AOD-9604 — Peptide Comparison

Adipotide vs AOD-9604 — Peptide Comparison Adipotide vs AOD-9604 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Adipotide 0.1–0.43 mg/kg AOD-9604 250–500 mcg Frequency Once daily Administration Subcutaneous injection Cycle Length 4-6 weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Gradual (3-4 weeks) Evidence Level Strong preclinical (extensive animal studies) Moderate human trials (Phase 1-2) Efficacy Fat Elimination Metabolic Improvement Speed of Results Fat Targeting Safety Profile Joint Support Technical Data Molecular Formula C111H206N36O28S2 Molecular Weight 2611.41 g/mol Half-Life ~24 hours Bioavailability High (subcutaneous injection) CAS Number 859216-15-2 C78H123N23O23S2 1815.1 g/mol ~3-4 minutes (plasma) High (subcutaneous) 221231-10-3 Protocols starting 0.10 mg/kg About 2 weeks before stepping up Adipotide is research-only and has never been approved for people. These numbers come from a dose-finding study in obese monkeys, where the dose was raised step by step every 2 weeks. The first human Phase 1 study started even lower, at 0.03 mg/kg daily. [2] standard 0.25 mg/kg About 2 weeks at this step Middle step in the monkey dose-finding study. Not an approved human dose. [2] advanced 0.43 mg/kg Up to ~3-4 weeks at this level (studies ran 28 days at the top dose) This was the best-working ("optimal") dose in obese monkeys, leading to about 10.6% body-weight loss over 28 days. It is from animal research and is not an approved or established human dose. [2] 250 mcg 2-4 weeks AOD9604 is a research peptide and not an approved medicine. Doses around 250 mcg under the skin are a common starting point in practice. In a human trial the most effective amount was about 1 mg per day. [1][5] 300-400 mcg A commonly used daily amount in practice. The largest human study found benefit up to about 1 mg/day with no extra gain from higher doses. [1][5] 500 mcg A higher amount sometimes used in practice. Going above roughly 1 mg/day did not improve results in the human trial. [1][5] Applications Targeted White Fat Reduction Adipotide specifically seeks out and destroys the blood vessels feeding white adipose tissue. Unlike diet or exercise that shrink fat cells, this peptide actually eliminates fat tissue by cutting off its blood supply - a completely unique mechanism. Stubborn Fat Deposits Because it targets the vasculature of fat tissue directly, Adipotide may be particularly effective for stubborn fat deposits that resist traditional methods. The peptide homes in on prohibitin receptors found specifically on blood vessels supplying fat tissue. Improving Insulin Resistance Primate studies showed remarkable improvements in insulin sensitivity - treated monkeys used about 50% less insulin after treatment. This makes it interesting for research into obesity-related metabolic dysfunction. Research Applications As a pioneering vascular-targeting peptide, Adipotide represents a new class of potential therapeutics. Its unique mechanism of targeting specific tissue vasculature has implications beyond obesity research. Targeted Fat Loss AOD-9604 shines when you want to target stubborn fat deposits. It works by mimicking how growth hormone breaks down fat, but without the side effects of actual HGH. Think of it as a smart missile that targets fat cells specifically. Body Recomposition Perfect for those who want to lose fat while maintaining muscle. Unlike many fat loss compounds, AOD-9604 doesn't affect muscle tissue or mess with your blood sugar levels—it's laser-focused on fat metabolism. Metabolic Enhancement Ideal for boosting your metabolism naturally. AOD-9604 increases fat oxidation (your body's ability to burn fat for fuel) without the jittery stimulant effects of caffeine or other thermogenics. Joint Health Support Emerging research shows AOD-9604 may help repair cartilage and support joint health. Studies in osteoarthritis models show it can reduce cartilage damage, making it a dual-purpose peptide for active individuals. Metabolically Safe Fat Loss Unlike many weight loss compounds, AOD-9604 doesn't raise blood sugar, doesn't affect insulin, and doesn't stimulate cell growth. It's one of the gentlest approaches to enhancing fat metabolism available. Common Elevated Serum Creatinine Proteinuria Glucosuria Reduced Appetite Uncommon Mild Dehydration Injection Site Reactions Serious Renal Tubular Dysfunction Injection site reactions Mild headache Flushing or warmth Fatigue Dizziness Allergic reaction Research Status FDA Status Research compound Safety Overview Adipotide has been extensively studied in mice, rats, and three species of primates with consistent results. The primary safety concern is dose-dependent kidney effects, which were reversible upon stopping treatment in all studies. No cardiovascular, neurological, or hepatic adverse events were observed. The compound shows remarkable selectivity - lean animals given the same doses experienced no weight loss, suggesting it specifically targets excess fat tissue. Contraindications xKidney disease or impaired renal function xPregnancy or breastfeeding xActive infections or compromised immune system xHistory of severe allergic reactions to peptides xDehydration or conditions affecting fluid balance Not FDA approved AOD-9604 has been studied in multiple human clinical trials involving thousands of participants. The safety profile is notably clean—it doesn't affect blood sugar, insulin levels, or cause the typical side effects of growth hormone. Phase 2 trials showed it was well-tolerated even at doses higher than typically used. The most common side effects are mild and injection-site related. xActive cancer or history of cancer xKnown allergy to growth hormone-derived peptides xChildren and adolescents Decision Guide Choose Adipotide if... Targeted fat reduction Improving insulin resistance Reducing stubborn white adipose tissue Research into vascular-targeted therapies Choose AOD-9604 if... Fat loss Body composition improvement Metabolic support Joint health support